Literature DB >> 27681121

Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.

Zachary M Parker1, Tracy Jo Pasieka2, George A Parker3, David A Leib4.   

Abstract

The interferon (IFN) response to viral pathogens is critical for host survival. In humans and mouse models, defects in IFN responses can result in lethal herpes simplex virus 1 (HSV-1) infections, usually from encephalitis. Although rare, HSV-1 can also cause fulminant hepatic failure, which is often fatal. Although herpes simplex encephalitis has been extensively studied, HSV-1 generalized infections and subsequent acute liver failure are less well understood. We previously demonstrated that IFN-αβγR-/- mice are exquisitely susceptible to liver infection following corneal infection with HSV-1. In this study, we used bone marrow chimeras of IFN-αβγR-/- (AG129) and wild-type (WT; 129SvEv) mice to probe the underlying IFN-dependent mechanisms that control HSV-1 pathogenesis. After infection, WT mice with either IFN-αβγR-/- or WT marrow exhibited comparable survival, while IFN-αβγR-/- mice with WT marrow had a significant survival advantage over their counterparts with IFN-αβγR-/- marrow. Furthermore, using bioluminescent imaging to maximize data acquisition, we showed that the transfer of IFN-competent hematopoietic cells controlled HSV-1 replication and damage in the livers of IFN-αβγR-/- mice. Consistent with this, the inability of IFN-αβγR-/- immune cells to control liver infection in IFN-αβγR-/- mice manifested as profoundly elevated aspartate transaminase (AST) and alanine transaminase (ALT) levels, indicative of severe liver damage. In contrast, IFN-αβγR-/- mice receiving WT marrow exhibited only modest elevations of AST and ALT levels. These studies indicate that IFN responsiveness of the immune system is a major determinant of viral tropism and damage during visceral HSV infections. IMPORTANCE: Herpes simplex virus 1 (HSV-1) infection is an incurable viral infection with the most significant morbidity and mortality occurring in neonates and patients with compromised immune systems. Severe pathologies from HSV include the blindness-inducing herpetic stromal keratitis, highly debilitating and lethal herpes simplex encephalitis, and generalized infections that can lead to herpes simplex virus-induced acute liver failure. While immune compromise is a known factor, the precise mechanisms that lead to generalized HSV infections are unknown. In this study, we used and developed a mouse model system in combination with real-time bioluminescence imaging to demonstrate the relative importance of the immune and nonimmune compartments for containing viral spread and promoting host survival after corneal infection. Our results shed light on the pathogenesis of HSV infections that lead to generalized infection and acute liver failure.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27681121      PMCID: PMC5110161          DOI: 10.1128/JVI.01473-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Hepatitis due to herpes simplex virus in marrow-transplant recipients.

Authors:  J R Johnson; S Egaas; C A Gleaves; R Hackman; R A Bowden
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

Authors:  D A Leib; D M Coen; C L Bogard; K A Hicks; D R Yager; D M Knipe; K L Tyler; P A Schaffer
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis.

Authors:  Jiehao Zhou; Stephen A Stohlman; David R Hinton; Norman W Marten
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 4.  Human herpes simplex virus: life cycle and development of inhibitors.

Authors:  M K Kukhanova; A N Korovina; S N Kochetkov
Journal:  Biochemistry (Mosc)       Date:  2014-12       Impact factor: 2.487

5.  In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts.

Authors:  K A Rader; C E Ackland-Berglund; J K Miller; J S Pepose; D A Leib
Journal:  J Gen Virol       Date:  1993-09       Impact factor: 3.891

Review 6.  Viral encephalitis.

Authors:  Peter G E Kennedy
Journal:  J Neurol       Date:  2005-03-11       Impact factor: 4.849

7.  Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection.

Authors:  Kristine-Ann G Buela; Robert L Hendricks
Journal:  J Immunol       Date:  2014-11-24       Impact factor: 5.422

8.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

Review 9.  Alphaherpesvirus Latency: A Dynamic State of Transcription and Reactivation.

Authors:  David C Bloom
Journal:  Adv Virus Res       Date:  2016-02-15       Impact factor: 9.937

10.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more
  6 in total

Review 1.  Herpes Simplex Virus Evasion of Early Host Antiviral Responses.

Authors:  Eduardo I Tognarelli; Tomás F Palomino; Nicolás Corrales; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

2.  Multiplex qPCR facilitates identification of betaherpesviruses in patients with acute liver failure of unknown etiology.

Authors:  Jéssica Vasques Raposo; Arthur Daniel Rocha Alves; Alexandre Dos Santos da Silva; Damião Carlos Dos Santos; Juliana Gil Melgaço; Otacílio C Moreira; Marcelo Alves Pinto; Vanessa Salete de Paula
Journal:  BMC Infect Dis       Date:  2019-09-04       Impact factor: 3.090

3.  Microglia Reduce Herpes Simplex Virus 1 Lethality of Mice with Decreased T Cell and Interferon Responses in Brains.

Authors:  Meng-Shan Tsai; Li-Chiu Wang; Hsien-Yang Tsai; Yu-Jheng Lin; Hua-Lin Wu; Shun-Fen Tzeng; Sheng-Min Hsu; Shun-Hua Chen
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

4.  Preclinical models of acute liver failure: a comprehensive review.

Authors:  Joshua Hefler; Braulio A Marfil-Garza; Rena L Pawlick; Darren H Freed; Constantine J Karvellas; David L Bigam; A M James Shapiro
Journal:  PeerJ       Date:  2021-12-09       Impact factor: 2.984

Review 5.  Insights into the pathogenesis of herpes simplex encephalitis from mouse models.

Authors:  Mathieu Mancini; Silvia M Vidal
Journal:  Mamm Genome       Date:  2018-08-23       Impact factor: 2.957

6.  Absence of the lectin-like domain of thrombomodulin reduces HSV-1 lethality of mice with increased microglia responses.

Authors:  Meng-Shan Tsai; Li-Chiu Wang; Hua-Lin Wu; Shun-Fen Tzeng; Edward M Conway; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Neuroinflammation       Date:  2022-03-11       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.